These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11374422)

  • 1. Reassuring effect of pravastatin on natural killer cell activity in stable renal transplant patients.
    Vaessen LM; van Miert PP; van Gelder T; Ijzermans JN; Weimar W
    Transplantation; 2001 Apr; 71(8):1175-9. PubMed ID: 11374422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pravastatin on acute rejection after kidney transplantation--a pilot study.
    Katznelson S; Wilkinson AH; Kobashigawa JA; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Cohen AH; Teraski PI
    Transplantation; 1996 May; 61(10):1469-74. PubMed ID: 8633373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
    Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of pravastatin in heart transplant recipients: implications of Kobashigawa et al.
    Gotto AM
    Curr Opin Lipidol; 1995 Dec; 6(6):341-3. PubMed ID: 8750244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N; Ohmori Y; Tsuji T; Oka T
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of pravastatin on hyperlipidemia in renal transplant recipients.
    Yoshimura N; Oka T; Okamoto M; Ohmori Y
    Transplantation; 1992 Jan; 53(1):94-9. PubMed ID: 1733092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone.
    Castelao AM; Grinyó JM; Castiñeiras MJ; Fiol C; Gilvernet S; Seron D; Torras J; Cruzado JM; Alsina J
    Transplant Proc; 1995 Aug; 27(4):2217-20. PubMed ID: 7652779
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.
    Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
    Seipelt IM; Crawford SE; Rodgers S; Backer C; Mavroudis C; Seipelt RG; Pahl E
    J Heart Lung Transplant; 2004 Mar; 23(3):317-22. PubMed ID: 15019641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypercholesterolemia with fluvastatin in kidney transplant patients.
    Melchor JL; Gracida C
    Transplant Proc; 1998 Aug; 30(5):2054. PubMed ID: 9723390
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia.
    Pan HY; DeVault AR; Brescia D; Willard DA
    Clin Ther; 1991; 13(3):368-72. PubMed ID: 1954638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression.
    Hedman M; Neuvonen PJ; Neuvonen M; Holmberg C; Antikainen M
    Clin Pharmacol Ther; 2004 Jan; 75(1):101-9. PubMed ID: 14749696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia.
    Strauss WE; Lapsley D; Gaziano JM
    Am Heart J; 1999 Mar; 137(3):458-62. PubMed ID: 10047626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
    Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
    Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
    Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
    Imagawa DK; Dawson S; Holt CD; Kirk PS; Kaldas FM; Shackleton CR; Seu P; Rudich SM; Kinkhabwala MM; Martin P; Goldstein LI; Murray NG; Terasaki PI; Busuttil RW
    Transplantation; 1996 Oct; 62(7):934-42. PubMed ID: 8878387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins improve visual field alterations related to hypercholesterolemia.
    Alcalá A; Jansen S; Téllez T; Gómez-Huelgas R; Pérez O; Egido J; Farkouh ME
    Atherosclerosis; 2010 Apr; 209(2):510-4. PubMed ID: 19892351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.